| Axon ID |
Name |
Description |
From price |
|
1887
|
PFI-1
|
BET bromodomain (BRD) inhibitor |
€75.00 |
|
1989
|
(+)-JQ1
|
Potent and selective BET bromodomain inhibitor |
€60.00 |
|
2245
|
RVX 208
|
BET bromodomain inhibitor specific for second bromodomains (BD2s) |
€65.00 |
|
2410
|
GSK 5959
|
Potent, cell permeable inhibitor of BRPF1 bromodomain |
€135.00 |
|
2594
|
CPI 0610
|
Selective and metabolically stable inhibitor of BET bromodomains |
Inquire |
|
2776
|
CD161
|
Potent, selective, and orally active BET bromodomain inhibitor |
€135.00 |
|
3037
|
BI-894999
|
Potent, selective and orally active BET inhibitor |
€165.00 |
|
3329
|
ODM-207
|
Highly potent, selective and orally active pan-BET inhibitor |
€140.00 |
|
3623
|
SGC-SMARCA-BRDVIII
|
Potent, highly selective and cell-active SMARCA2/4 and PB1(5) bromodomain inhibitor |
€90.00 |
|
3716
|
BMS-986158
|
BET bromodomain (BRD) inhibitor |
Inquire |
|
3696
|
ABBV-075
|
Highly potent and orally bioavailable BET bromodomain (BRD) inhibitor |
€110.00 |
|
3833
|
AZD5153 HNT salt
|
Potent, selective, and orally available BET/BRD4 bromodomain inhibitor |
Inquire |
|
3860
|
I-BET726
|
Potent and selective, tetrahydroquinoline-based small molecule ligand binding to BET proteins |
Inquire |
|
3822
|
(+)-JQ1 carboxylic acid
|
(+)-JQ1 derivative; PROTAC precursor |
€110.00 |
|
3921
|
GSK046
|
Domain-selective and orally active inhibitor of BET with immunomodulatory activity |
Inquire |
|
3922
|
dBET1
|
BET bromodomain degrader |
Inquire |
|
3933
|
CCS-1477
|
Potent, selective and orally bioavailable inhibitor of the Bromodomain of p300 and CBP |
Inquire |
|
3944
|
ARV-825
|
Potent and selective protein BRD4 degrader |
Inquire |
|
3956
|
ABBV-744
|
First-in-class highly BDII (Bromodomain II)-selective BET bromodomain inhibitor |
Inquire |
|
3873
|
(-)-JQ-1
|
Inactive enantiomer of (+)-JQ1 |
€120.00 |
|
4134
|
I-BET762
|
BET bromodomain inhibitor |
Inquire |
|
4135
|
I-BET151
|
BET bromodomain inhibitor |
Inquire |